Nyxoah Inc.
Nasdaq NYXH · Mont-Saint-Guibert, Belgium
Works in Neurology · Respiratory
Nyxoah Inc. is a clinical trial sponsor based in Mont-Saint-Guibert, Belgium, listed as Nasdaq NYXH. It has 1 active clinical trial with 229 planned participants, in Neurology and Respiratory.
Trial track record · since 2021
Financials · Nasdaq NYXH
Fundraising
Pipeline · 1 active trial
| Stage | Trial | Status |
|---|---|---|
Questions about Nyxoah Inc
Nyxoah Inc is lead sponsor of 1 active clinical trial on ClinicalTrials.gov, with 229 planned participants, in Neurology, Respiratory. Since 2021 it has completed 0 trials and stopped 0 early.
Nyxoah Inc is based in Mont-Saint-Guibert, Belgium and is listed as Nasdaq NYXH. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Nyxoah Inc; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-06-22.
Approve Suite is not affiliated with Nyxoah Inc..
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.